I thank the Member for that question, and, of course, I’m sure the Member will welcome the announcement by the Minister for Social Services and Public Health that, in future, women will be screened for the main cause of cervical cancer instead—the high-risk human papilloma virus, HRHPV. Under those new arrangements, women will continue to receive what is commonly known as a smear test, but the sample will then be tested for HRHPV.

Yes, the number of women invited for screening has declined as a result of changes in the age range, and in frequency of invitation, which was introduced in 2013, when we stopped inviting women aged 20-25. But we, of course, now need to recognise that we’re going to be implementing better and more user-friendly testing for both cervical cancer screening and, indeed, for bowel cancer screening. The test for HPV is more sensitive and it will allow the NHS to identify those requiring treatment more effectively. So, a pilot programme reaching around 20 per cent of women will roll out across Wales from April of this year, and a full roll-out is expected to start next year, 2018-19.